Cases & Deals

Dendreon completes $426.9 million public offering of Common Stock

Clients Dendreon Corporation

Jones Day represented Dendreon Corporation, a biotechnology company focused on the discovery, development and commercialization of therapeutics that improve cancer treatment options for patients, in connection with the $426.9 million public offering of Common Stock, underwritten by J.P. Morgan Securities Inc., Deutsche Bank Securities Inc., Citigroup Global Markets Inc., Lazard Capital Markets LLC, Leerink Swann LLC, Morgan Stanley & Co. Incorporated, and Needham & Company LLC.